Literature DB >> 10681657

High protein/energy vs. standard protein/energy nutritional regimen in the treatment of malnourished hemodialysis patients.

M K Kuhlmann1, F Schmidt, H Köhler.   

Abstract

Although malnutrition is frequently encountered in maintenance hemodialysis (MHD) patients, a clear method of treating this complication is still lacking. Failure of nutritional support regimens may be due to inadequate support of dietary needs. Therefore, a high vs. standard or low protein/energy dietary regimen was studied in malnourished MHD patients. A total of 18 malnourished MHD patients selected according to subjective global assessment (SGA)-scores and biochemical indicators of malnutrition (serum albumin <40 g/l, cholesterol <200 mg/dl, prealbumin <30 mg/dl; two out of three) were assigned to three treatment groups: (A: 45 kcal/kg/d and 1.5 g protein/kg/d; B: 35 kcal/kg/d and 1.2 g protein/kg/d; C: spontaneous intake supplemented with 10% of mean protein and energy intake). A and B received food supplements at appropriate dosing to reach the targeted nutritional intake. During 3-month follow-up nutrient intake was assessed by repeated 4-day dietary diaries. Compliance and tolerance was good in each group. Weight gain (1.2+/-0.4 kg) was observed in group A, but not in B and C. Serum albumin levels increased by 1.0+/-0.5 g/l in group A, but not in B and C. Prealbumin and cholesterol levels were unaffected. Weight change correlated with mean dietary energy intake, but not with mean dietary protein intake. We conclude that prescription of 45 kcal/kg/d and 1.5 g protein/kg/d may be necessary to achieve weight gain and improvement of nutritional indices in malnourished MHD pts. Oral food supplements can be used safely and effectively to increase nutrient intake to high levels in these patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10681657     DOI: 10.1159/000057465

Source DB:  PubMed          Journal:  Miner Electrolyte Metab        ISSN: 0378-0392


  6 in total

Review 1.  Diets and enteral supplements for improving outcomes in chronic kidney disease.

Authors:  Kamyar Kalantar-Zadeh; Noël J Cano; Klemens Budde; Charles Chazot; Csaba P Kovesdy; Robert H Mak; Rajnish Mehrotra; Dominic S Raj; Ashwini R Sehgal; Peter Stenvinkel; T Alp Ikizler
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

2.  Role of Growth Hormone Deficiency and Treatment in Chronic Kidney Disease.

Authors:  Diptesh Gupta; Michael Gardner; Adam Whaley-Connell
Journal:  Cardiorenal Med       Date:  2011-07-26       Impact factor: 2.041

Review 3.  Dietary advice with or without oral nutritional supplements for disease-related malnutrition in adults.

Authors:  Christine Baldwin; Marian Ae de van der Schueren; Hinke M Kruizenga; Christine Elizabeth Weekes
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

4.  Sarcopenia: a major challenge in elderly patients with end-stage renal disease.

Authors:  Maciej Domański; Kazimierz Ciechanowski
Journal:  J Aging Res       Date:  2012-03-28

5.  Wasting in chronic kidney disease.

Authors:  Robert H Mak; Alp T Ikizler; Csaba P Kovesdy; Dominic S Raj; Peter Stenvinkel; Kamyar Kalantar-Zadeh
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-03-16       Impact factor: 12.910

6.  Long-term oral nutrition supplementation improves outcomes in malnourished patients with chronic kidney disease on hemodialysis.

Authors:  Siren Sezer; Zeynep Bal; Emre Tutal; Mehtap Erkmen Uyar; Nurhan Ozdemir Acar
Journal:  JPEN J Parenter Enteral Nutr       Date:  2014-01-16       Impact factor: 4.016

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.